ADAR and hepatocellular carcinoma: Androgen receptor (AR), a transcriptional activator of ADAR1 promoter, could suppress circARSP91 expression by upregulating ADAR1 p110, eventually leading to HCC tumor growth both in vitro and in vivo (You et al., 2015; Shi et al., 2017).